Skip to main content

What the FDA labels say about taking them together

Itraconazole and trastuzumab emtansine

Trastuzumab emtansine's FDA label of April 1, 2026 names itraconazole in its drug interactions section; the itraconazole labels PlainMeds reads (2) do not name trastuzumab emtansine. The trastuzumab emtansine label: “Concomitant use of strong CYP3A4 inhibitors with KADCYLA should be avoided due to the potential for an increase in DM1 exposure and toxicity.”

Check it at the source: the itraconazole FDA label on DailyMed (effective July 13, 2026, Janssen Pharmaceuticals, Inc.); the trastuzumab emtansine FDA label on DailyMed (effective April 1, 2026).

What does the itraconazole label say about trastuzumab emtansine?

Itraconazole's label (effective July 13, 2026) and its 1 other brand-application label do not name trastuzumab emtansine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (SPORANOX), Janssen Pharmaceuticals, Inc., effective July 13, 2026 (SPL set a4d555fa-787c-40fb-bb7d-b0d4f7318fd0), via openFDA; the full label on DailyMed

What does the trastuzumab emtansine label say about itraconazole?

Trastuzumab emtansine label, drug interactions

Concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, and voriconazole) with KADCYLA should be avoided due to the potential for an increase in DM1 exposure and toxicity.

Source: FDA drug label (KADCYLA), Genentech, Inc., effective April 1, 2026 (SPL set 23f3c1f4-0fc8-4804-a9e3-04cf25dd302e), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

11Itraconazole generic labelers
0Trastuzumab emtansine generic labelers
ItraconazoleTrastuzumab emtansine
Labeled forFungal infectionsBreast cancer
Boxed warningYesYes
Pharmacy cost (NADAC)$0.910 per capsule 100 mg capsulen/a
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?